Vancouver, BC, January 2, 2019--Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, announced that Mark H.N. Corrigan, MD, a current member of the Company's Board of Directors, has been named Correvio's next Chief Executive Officer.
|